Update on HAART in HIV
- 1 December 2005
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 44, S100-S103
- https://doi.org/10.1016/j.jhep.2005.11.021
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohortAIDS, 2005
- Treatment for Adult HIV InfectionJAMA, 2004
- Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 InfectionNew England Journal of Medicine, 2004
- Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 InfectionNew England Journal of Medicine, 2003
- Improved Outcomes with Earlier Initiation of Highly Active Antiretroviral Therapy Among Human Immunodeficiency Virus–Infected Patients Who Achieve Durable Virologic Suppression: Longer Follow‐Up of an Observational Cohort StudyThe Journal of Infectious Diseases, 2003
- Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studiesThe Lancet, 2003
- Management of Metabolic Complications Associated With Antiretroviral Therapy for HIV-1 Infection: Recommendations of an International AIDS Society–USA PanelJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesThe Lancet, 2002
- Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV InfectionNew England Journal of Medicine, 2002
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998